chr2-47803479-G-T
Variant summary
The NM_000179.3(MSH6):c.3232G>T (p.Val1078Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene MSH6 is a tumor suppressor gene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The gene MSH6 is a known oncogene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The gene MSH6 is a cancer driver gene (CancerMine: 1 TSG, 8 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V1078A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 134855); p.V1078I: Uncertain_significance (ClinVar VariationId 3693927, 1 star); p.V1078L: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127582); p.V1078= (synonymous): Benign (ClinVar VariationId 3903497, 1 star); p.V1078= (synonymous): Benign/Likely_benign (ClinVar VariationId 924451, 2 stars)
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000179.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | MANE Select | c.3232G>T p.Val1078Leu | missense | Exon 5 of 10 | Prot: NP_000170.1 UniProt: | |
MSH6 | c.3328G>T p.Val1110Leu | missense | Exon 6 of 11 | Prot: NP_001393724.1 | ||
MSH6 | c.3238G>T p.Val1080Leu | missense | Exon 5 of 10 | Prot: NP_001393742.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | TSL:1MANE Select | c.3232G>T p.Val1078Leu | missense | Exon 5 of 10 | Prot: ENSP00000234420.5 UniProt: | |
MSH6 | TSL:1 | n.*2579G>T | 3_prime_UTR | Exon 4 of 9 | Prot: ENSP00000405294.1 UniProt: | |
MSH6 | TSL:1 | n.*2579G>T | non_coding_transcript_exon | Exon 4 of 9 | Prot: ENSP00000405294.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:33 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 18 | |
AlphaMissense | Benign | 0.12 | |
BayesDel_addAF | Benign | 0.0078 | T |
BayesDel_noAF | Benign | -0.23 | |
CADD | Benign | 19 | |
DANN | Benign | 0.95 | |
DEOGEN2 | Benign | 0.092 | T |
Eigen | Benign | -0.32 | |
Eigen_PC | Benign | -0.16 | |
FATHMM_MKL | Uncertain | 0.90 | D |
FuncVEP CTI | Benign | 0.0095 | |
GPN-Star LLR | N/A | -5.0 | |
GPN-Star score | N/A | 5.0 | |
LIST_S2 | Benign | 0.84 | T |
M_CAP | Benign | 0.043 | D |
MetaRNN | Benign | 0.25 | T |
MetaSVM | Benign | -0.70 | T |
Mutation Taster | N/A | 80/20 | polymorphism |
MutationAssessor | Benign | 1.5 | L |
PhyloP100 | Benign | 2.3 | |
popEVE | Benign | -2.8 | |
PrimateAI | Benign | 0.27 | T |
PROVEAN | Benign | -0.73 | N |
REVEL | Benign | 0.18 | |
Sift | Benign | 0.38 | T |
Sift4G | Benign | 0.32 | T |
Varity_R | N/A | 0.14 | |
VESM-3B | Benign | -5.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.